Do thyroid hormones mostly circulate bound to proteins, and does amino-acid availability support their transport proteins?

Thyroid-hormone transport is strongly protein-dependent, whereas the nutritional portion of the claim is best understood as a general protein-synthesis principle rather than evidence that isolated amino-acid deficits commonly cause thyroid disease.

Clinical and transport evidence

• More than 99% of circulating thyroid hormone is protein-bound: only approximately 0.03% of T4 and 0.3% of T3 is free. TBG carries roughly three-quarters of T4 and T3; transthyretin contributes about one-fifth of T4 transport, and albumin provides substantial lower-affinity binding capacity.
• Because binding proteins determine the large bound pool, changes in TBG can alter total T4/T3 while free hormone and TSH remain normal. Pregnancy, estrogen exposure, inherited TBG variation, and malnutrition can therefore complicate interpretation of total-hormone measurements.

Nutrition and protein synthesis

• Amino acids are required substrates for hepatic plasma-protein production. Nutrient sensing, including leucine-responsive mTOR-dependent translation, regulates this process, and transthyretin falls with amino-acid restriction.
• In protein-energy malnutrition, reductions in transthyretin and other carrier proteins accompany impaired hepatic protein synthesis and may lower measured total T3/T4; these changes can improve with nutritional rehabilitation. This does not establish that isolated amino-acid insufficiency consistently lowers TBG or produces primary hypothyroidism.
• Thyroid-related enzymes are proteins, making amino-acid adequacy biologically necessary for their synthesis. However, direct evidence that amino-acid restriction reduces production of deiodinases, thyroid peroxidase, or other thyroid-specific enzymes is not established.

Practical implications

• In suspected thyroid dysfunction with altered nutritional status or binding-protein abnormalities, prioritize TSH and free T4 over total T4/T3 alone. If results conflict with the clinical picture, equilibrium dialysis or ultrafiltration with LC-MS/MS can better address assay interference from abnormal binding.

Bottom line

• The transport claim is firmly established; amino-acid adequacy supports carrier-protein synthesis, while a specific clinically demonstrated effect on thyroid-enzyme production remains mechanistically plausible rather than directly proven.